Cargando…
Hyperlipidemia as a risk factor for Trousseau syndrome-related cerebral infarction in patients with advanced gastrointestinal cancer
Trousseau syndrome-related cerebral infarction rarely occurs during chemotherapy in patients with gastrointestinal (GI) cancer, and its clinical features remain unclear. The present study aimed to examine the clinical features of Trousseau syndrome-related cerebral infarction developed during chemot...
Autores principales: | Tanaka, Toshimitsu, Suzuki, Hiroyuki, Miwa, Keisuke, Ushijima, Tomoyuki, Nagasu, Sachiko, Fukahori, Masaru, Ishii, Kaito, Nakamura, Toru, Iwamoto, Hideki, Masuda, Atsutaka, Sakaue, Takahiko, Koga, Hironori, Akagi, Yoshito, Murotani, Kenta, Torimura, Takuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353866/ https://www.ncbi.nlm.nih.gov/pubmed/35949619 http://dx.doi.org/10.3892/ol.2022.13437 |
Ejemplares similares
-
A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer
por: Fukahori, Masaru, et al.
Publicado: (2021) -
mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma
por: Matsunaga, Mototsugu, et al.
Publicado: (2016) -
Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
por: Matsunaga, Mototsugu, et al.
Publicado: (2016) -
Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
por: Shigeto, Kota, et al.
Publicado: (2020) -
Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer
por: Shigyo, Hirona, et al.
Publicado: (2023)